SAB Biotherapeutics Inc Net Asset Quality Index
SAB Biotherapeutics Inc net asset quality index. SAB Biotherapeutics Inc (SABS) has a Net Asset Quality Index of 90.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $238.21 Million minus total liabilities of $23.43 Million yields net assets of $214.78 Million. A higher index indicates a stronger, lower-leverage balance sheet. See SAB Biotherapeutics Inc shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of SAB Biotherapeutics Inc (2019–2025)
Net asset quality index of SAB Biotherapeutics Inc from 2019 to 2025. This chart shows how SAB Biotherapeutics Inc's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the index stands at 90.2%, representing net assets of $214.78 Million against total assets of $238.21 Million USD. Check SAB Biotherapeutics Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
SAB Biotherapeutics Inc Net Asset Quality Index by Year (2019–2025)
SAB Biotherapeutics Inc net asset quality index by year from 2019 to 2025. The table below presents the year-by-year Net Asset Quality Index for SAB Biotherapeutics Inc from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of SAB Biotherapeutics Inc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.7% | $151.49 Million | $172.81 Million | $21.32 Million | ▲ +28.9 pp |
| 2024 | 58.8% | $25.97 Million | $44.20 Million | $18.23 Million | ▼ -9.5 pp |
| 2023 | 68.3% | $57.30 Million | $83.94 Million | $26.64 Million | ▲ +7.2 pp |
| 2022 | 61.0% | $31.06 Million | $50.90 Million | $19.85 Million | ▲ +13.5 pp |
| 2021 | 47.5% | $38.55 Million | $81.14 Million | $42.59 Million | ▼ -21.5 pp |
| 2020 | 69.0% | $39.01 Million | $56.54 Million | $17.53 Million | ▲ +81.8 pp |
| 2019 | -12.8% | $-2.31 Million | $18.00 Million | $20.31 Million | — |